New England biotechs and IT startups don’t seem to indicate a summer slowdown. They’ve been inking some pretty massive financing deals this week, as well as an acquisition or two.
—Cambridge, MA-based drug developer Aveo Pharmaceuticals (NASDAQ: AVEO) raised $100 million, selling 5.75 million shares of stock at $17.50 apiece in an underwritten public offering. Aveo had $233 million in cash and investments as of March 31 and enough cash to operate through 2012, according to federal documents.
—Burlington, MA-based Nuance Communications (NASDAQ: NUAN) acquired Zurich-based embedded speech software firm SVOX, for 87 million Euros (about U.S. $125 million), in a mix of upfront cash and cash and stock over the next two years.
—Westford, MA-based Aylus Networks raised $16 million to put toward its software for improving video communications on mobile phones. The deal was led by London-based m8 Capital, with participation from previous Aylus investors Matrix Partners and North Bridge Venture Partners.
—Performable, a Cambridge-based marketing automation startup, was acquired by Cambridge-based HubSpot for an undisclosed sum. Performable’s 18 staffers will join HubSpot, a marketing tech company with more than 260 employees now, at its Kendall Square digs, with Performable founder David Cancel becoming HubSpot’s chief product officer.
—1366 Technologies, a Lexington, MA-based developer of silicon wafer technology for solar cells, said that it received a conditional commitment from the U.S. Department of Energy for a $150 million loan guarantee.
—Boston-based ad tech startup OwnerIQ nabbed a $7 million investment from its existing backers, Atlas Venture, CommonAngels, Kepha Partners, and … Next Page »